Clinical Accelerator, Clinical and Scientific Advisory Committee Padmanee Sharma, MD, PhD The University of Texas MD Anderson Cancer Center Houston, TX Dr. Padmanee Sharma is a Professor in the departments of Genitourinary Medical Oncology and Immunology, and the Scientific Director for the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center. She is also the Co-Director of Parker Institute for Cancer Immunotherapy at MD Anderson Cancer Center. Dr. Padmanee Sharma is a trained medical oncologist and immunologist whose research work is focused on investigating mechanisms and pathways within the immune system that are responsible for tumor rejection and clinical benefit. She is the Principal Investigator of multiple immunotherapy clinical trials and conducts translational laboratory studies related to these trials. Her studies enable development of novel immunotherapy strategies for the treatment of cancer patients. Dr. Sharma received the Emil Frei III Award for Excellence in Translational Research in 2016 and was inducted into the American Society for Clinical Investigation (ASCI) in 2018. She is the recipient of the 2018 William B. Coley Award for Distinguished Research in Tumor Immunology. In addition to the CRI Scientific Advisory Council, she is a member of the CRI Clinical Accelerator Clinical and Scientific Advisory Committee.
